Skip to main content
. 2017 May 19;2017(5):CD011598. doi: 10.1002/14651858.CD011598.pub2

28.8. Analysis.

28.8

Comparison 28 Parenteral ‐ Serious adverse event maximum follow‐up, Outcome 8 Serious adverse events ‐ participants characterised as 'at nutritional risk' due to biomarkers or anthropometrics.